HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuromuscular Complications of Systemic Amyloidosis.

Abstract
Systemic amyloidosis is characterized by extracellular deposition of insoluble fibrillar proteins in multiple tissues, frequently at a distance from the site of synthesis. The 2 most common forms, light chain (AL) and transthyretin (ATTR) amyloidosis can cause peripheral neuropathy and, rarely, myopathy. Diagnosis can be challenging, and abundant suspicion is required to identify patients. As neurological manifestations of amyloidosis may precede involvement of other organs by several years, recognizing amyloid neuropathy and myopathy are crucial, especially in this new and exciting era of effective therapies for AL and ATTR neuropathy. This review will focus on the neuromuscular manifestations of AL and ATTR amyloidosis, diagnostic approaches, and recent advances in the treatment of amyloid neuropathy.
AuthorsDina Namiranian, Stefanie Geisler
JournalThe American journal of medicine (Am J Med) Vol. 135 Suppl 1 Pg. S13-S19 (04 2022) ISSN: 1555-7162 [Electronic] United States
PMID35104443 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2022 Elsevier Inc. All rights reserved.
Chemical References
  • Prealbumin
Topics
  • Amyloid Neuropathies (complications)
  • Amyloid Neuropathies, Familial (complications, diagnosis, therapy)
  • Humans
  • Muscular Diseases
  • Prealbumin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: